Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The BOC Group, formerly known as the British Oxygen Company, is a leading global provider of industrial and medical gases and is currently a subsidiary of Linde plc. In the healthcare sector, the company operates as BOC Healthcare, supplying essential medical gases such as oxygen, nitrous oxide (Entonox), and nitric oxide, alongside specialized respiratory therapies and homecare services. BOC's products are critical in clinical settings for anesthesia, intensive care, and emergency medicine, as well as for managing chronic conditions like COPD and sleep apnea. Following its acquisition by Linde in 2006, BOC has maintained its brand identity in several key markets, including the UK and Ireland, where it remains a primary supplier to national health services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BOC Group.